Peter Howsam, VP Sales and Marketing BW USA

Howsam was with BW between 1970 and 1983

The interview looks at the company from the marketing viewpoint. Throughout there is comparison of BW practices with those of SmithKline French and Warner-Lambert.

Topics discussed include:

* general biography

* company structure in 1970

* corporate culture, particularly in light of a charity being the only shareholder.

* internal communication of information and communication between the research staff and the sales staff

* relationship with UK company and the differing practices between UK and USA

*detailed look at marketing/ marketing strategy within BW and the changes Howsam brought

* Dr Fred Wrigley

* over the counter medicines, specifically marketing strategies

* licensing

* issues of marketing within different countries and use of expatriate staff vs nationals * collaboration with Roche over Septrin/Septra

* George Hitching

* product management and planning

* Bill Sullivan

* advertising

* generic drugs

* Dr Warlock

Products discussed specifically: Septrin/Septra; Empirin and removal of phenacetin from the formula; Zovirax; Zyloprim; AZT [product name Retrovir]; Actifed and Sudafed; Linoxin

2 audiocassettes Tape 14

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.